Filing Flows › Angiodynamics (ANGO) › Who owns the stock
Who owns Angiodynamics (ANGO) stock
152 funds reported Angiodynamics (ANGO) shares in their latest 13F filings, worth $530M in all. The largest holder is BlackRock ($49.5M). Last quarter 77 funds added to their stakes and 64 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| BlackRock | 3,803,232 | $49.5M | increase | 2026-06-30 |
| Point72 Asset Management, L.P. | 3,062,517 | $39.8M | decrease | 2026-06-30 |
| Systematic Financial Management LP | 2,640,214 | $34.3M | increase | 2026-06-30 |
| Vanguard Group | 2,436,833 | $31.3M | increase | 2025-12-31 |
| Armistice Capital, LLC | 2,198,000 | $28.6M | increase | 2026-06-30 |
| Royce & Associates LP | 1,969,835 | $25.6M | increase | 2026-06-30 |
| Broadfin Holdings LLC | 1,818,533 | $23.7M | decrease | 2026-06-30 |
| Vanguard Capital Management LLC | 1,694,716 | $22.0M | decrease | 2026-06-30 |
| Kotler Kevin | 1,713,789 | $22.0M | base | 2025-12-31 |
| Weber Capital Management LLC | 1,349,902 | $20.8M | decrease | 2026-09-30 |
| Nuveen, LLC | 1,199,358 | $15.6M | decrease | 2026-06-30 |
| Geode Capital Management, LLC | 1,020,658 | $13.3M | increase | 2026-06-30 |
| Dimensional Fund Advisors LP | 969,497 | $12.6M | increase | 2026-06-30 |
| State Street | 958,167 | $12.5M | decrease | 2026-06-30 |
| Bastion Asset Management | 923,270 | $10.8M | decrease | 2026-06-30 |
Angiodynamics' latest quarter
Angiodynamics, Q1 FY27: revenue $80.9M (+7% year over year), operating margin -9.0%, net loss $7.1M, operating cash flow −$15.3M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most ANGO stock?
By the latest 13F filings: BlackRock ($49.5M); Point72 Asset Management, L.P. ($39.8M); Systematic Financial Management LP ($34.3M); Vanguard Group ($31.3M); Armistice Capital, LLC ($28.6M).
What is the short interest in ANGO?
1,916,701 shares were sold short at the 2026-10-15 settlement, 48.05% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.